Dr. Kraut is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-8619Fax+1 614-293-6420
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1975 - 1977
UPMC Medical EducationResidency, Internal Medicine, 1972 - 1975
Lewis Katz School of Medicine at Temple UniversityClass of 1972
Certifications & Licensure
OH State Medical License 1975 - 2024
PA State Medical License 1973 - 1978- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer Start of enrollment: 1997 Jul 01
- Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer Start of enrollment: 1999 Oct 01
- Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer Start of enrollment: 2000 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsNCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.Elizabeth A Griffiths, Vivek Roy, Laura Alwan, Kimo Bachiashvili, John Baird
Journal of the National Comprehensive Cancer Network. 2022-05-01 - 110 citationsCancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Michael B. Streiff, Bjorn Holmstrom, Dana Angelini, Aneel A. Ashrani, Amro Elshoury
Journal of the National Comprehensive Cancer Network. 2021-10-15 - 73 citationsA phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Onco...Chatchada Karanes, Kenneth J. Kopecky, David R. Head, M. R. Grever, Harry E. Hynes
Leukemia Research. 1999-09-01
Abstracts/Posters
- Cardiac Injury and Microvascular Ischemia in Sickle Cell DiseaseEric H. Kraut, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- A Retrospective Study of Clinical and Laboratory Characteristics in Patients Diagnosed with Platelet Storage Pool Deficiency2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- Easy bruisingKraut EH
http://www.uptodate.com/contents/easy-bruising
UpToDate, Wolters Kluwer Health - 2012-03-29
Grant Support
- A Phase I Study Of Oxaliplatin In Combination With PaclitaxelNational Center For Research Resources2004
- Phase I Study Of Oxaliplatin In Combination With PaclitaxelNational Center For Research Resources2001
- Phase I Study Of Oxaliplatin In Combination With PaclitaxelNational Center For Research Resources2000
- Phase II Clinical Trials ConsortiumNational Cancer Institute1999
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
